text:
Lionsgate has released the final trailer for The Hunger Games: Mockingjay Part 2 and it is just as powerful as you expected. The movie is out November 20 and tickets are on sale now!
Willow is currently featured in Flaunt Magazine's #CALIFUK issue. You can read the article online here, which features a quick biography and some sweet words from Jennifer Chambers Lynch, writer/director of A Fall From Grace. The article also features a beautiful photo of Willow by Yoshino. Check it out!
Earlier today, Willow attended the first press conference for her new film The Wonder 3D in Beijing. It has been revealed that the movie will being filming on September 26 and has an expected summer 2016 release! It will be filming in Qingdao, China as well as Auckland, New Zealand. For more information on the film, click here. I have added some photos of Willow at the conference to the gallery and will add any more as they become available.
Exciting news! Willow's next project, The Wonder 3D, is about to begin production. Willow was cast as the lead Rachel 3 years ago and is currently in China to begin filming. A press conference is set to take place in Beijing on September 20th. It has not been confirmed whether or not Willow will attend, but it'll be exciting to hear more information about the film (EDIT: Willow will be attending Sunday's press conference, so stay tuned)! I have added a brief plot summary as well as a link to a more detailed version. Enjoy!
A group of schoolkids follow a rainbow that magically transports them to China, where they find themselves pursued by a mysterious organization as well as the cause of a major natural disaster. (READ MORE)
A new trailer for The Hunger Games: Mockingjay Part 2 has been released and lucky for us, it's all Prim. The trailer features clips of Prim and Katniss from the previous films and really highlights her importance to the series. Not to mention an extended clip from Prim and Katniss's dance at Finnick's wedding. Watch it below!
Willow is currently at the 2015 Teen Choice Awards looking beautiful as ever in Balmain! Willow is there to support Mockingjay Part One which is nominated for 6 awards including Choice Movie (Sci-fi/Fantasy). The awards show will live at 8pm ET on Fox. I will also be adding photos/videos from the event as they appear.
Last night, Willow attended the Kids Choice Awards Mexico in Mexico City. Willow represented Mockingjay Part One which won the award for "Favorite Movie". I have added photos to the gallery! Don't forget to vote Willow as "Best Dressed" !
The first official full-length trailer for The Hunger Games: Mockingjay Partt 2 is HERE and it's absolutely amazing! Don't miss the final chapter, in theatres November 20.


text:
Cart Checkout 0
Your Help is Here! 800.743.3206
VIP Membership Terms: Normally $24.99 per year, but your Web Exclusive deal means you enjoy 3 months of VIP Family Benefits for $1.99. Check out your savings and benefits below.
Cancellation: Rest assured you can cancel your new membership at any time during the year at a pro-rated rate, simply call your VIP Hotline at 800.543.7309 or click here to submit your cancellation request. Benefits and prices are subject to change.
Want more info? Click here and read 'til your heart's content or call your VIP Hotline at 800.543.7309
Get the Latest, Sign Up Now!
Men's Nike
Y20 Track Pant
Dri-FIT Element Half Zip
Women's Nike
Modern Embossed Tempo Short
Element Hoody
Element Half Zip
Printed 2" Rival Short
Mod Tempo Emboss Run Short
Epic Run Boy Short
Lined Woven Skirt
Swift Tight
Element Shield Full Zip Jacket
Dri-Fit Knit Long Sleeve
Element Shield Full Zip
Pro Hyperwarm Embossed Crew
SW Pant
Knit Running Short
Relay LS
Element Jacquard Half Zip
Gym Vintage Full Zip Hoodie
Miler Long Sleeve
Miler Long Sleeve Top
7" Phenom 2-in-1 Short
Dri-Fit Wool Crew
Back to top
ENJOY YOUR BIGGEST BENEFITS EVERY DAY Get FREE Shipping every day • Your WARP SPEED PROMISE • 90-Day Ultimate Test Run On Shoes • Tons More Perks! JOIN NOW!! �
Become a Fan & Follow Us.

subset: commoncrawl


text:
Phil Inglima is a partner in Crowell & Moring's White Collar & Regulatory Enforcement Group. He has litigated a broad range of criminal and civil matters in trial and appellate courts, with an emphasis on criminal frauds and parallel civil and regulatory enforcement proceedings. Phil frequently conducts internal investigations for corporations, with recent efforts focusing on the Foreign Corrupt Practices Act, the Federal False Claims Act, procurement fraud, bribery, false statements, and potential environmental crimes. He has counseled companies in the development and implementation of compliance programs, and has guided clients through regulatory reporting and disclosure processes. He also has extensive experience in handling congressional investigations and professional responsibility proceedings. In high-stakes, high profile matters, he has achieved outstanding results for a wide variety of corporate and individual clients over the past 25 years.
Phil has tried criminal and civil cases in both federal and state courts. He has argued federal appeals and post-judgment petitions, participated in arbitrations and mediations, and has represented clients in connection with professional responsibility proceedings. For the past several years, Phil has been recognized by clients and peers as a leading lawyer in Chambers USA in the areas of Litigation and White Collar Crime & Government Investigations, and both Super Lawyers and The Best Lawyers In America have repeatedly rated him as a leading lawyer in White Collar Criminal Defense.
Prior to joining Crowell & Moring, Phil's extensive white collar experience included nearly two years of service as a Senior Associate Independent Counsel in the investigation of then-Secretary of the Interior Bruce Babbitt. On that probe, Phil led a team examining allegations of perjury, bribery, improper influence peddling and campaign finance fraud involving national political organizations and numerous high legislative and executive offices. This role drew upon his experience representing government officials and businessmen in public corruption and fraud prosecutions during his more than eight years in private practice with Plato Cacheris.
A 1984 graduate of Georgetown University's College of Arts & Sciences and a 1988 graduate of Georgetown Law Center, Phil remains actively engaged in the Georgetown community. From 2006 to 2008, he served as President of Georgetown's Alumni Association and a member of the University's Board of Directors. He also has served as an adjunct professor at Georgetown Law Center, teaching a course in Federal White Collar Crime.
Phil began his career as law clerk to the Honorable June L. Green of the U.S. District Court for the District of Columbia. He is a member of the state and federal bars of D.C., New York, and the U.S. Supreme Court. Phil has been an active volunteer in the D.C. Bar, having chaired the Criminal Law steering committee, the Council on Sections and the Nominations Committee. He is a member of The Barristers and The Lawyers Club of Washington.
Phil and his wife and three children reside in the District of Columbia.
Admitted to practice: District of Columbia, New York
Washington, D.C.-based White Collar & Regulatory Enforcement Group partner, Philip T. Inglima, speaks to Global Investigations Review regarding his experience with subpoenas being blocked by a judge, even when it appears that all the appropriate steps have been taken to avoid a waiver or broad disclosure of the privileged materials. "These types of subpoena requests are becoming routine now, so companies are having to be ever more careful in making disclosures or presenting evidence to the DOJ so as not to waive attorney-client privilege and work product protection," states Inglima. "Delivering limited presentations orally is one way of reducing the risk."
Crowell & Moring's White Collar & Regulatory Enforcement Group has been named as one of Law360's 10 "FCPA Powerhouses" for its prowess handling Foreign Corrupt Practice Act (FCPA) matters. The Law360 editors noted, "With Foreign Corrupt Practices Act experience tracing back to the firm's founding in the late 1970s, Crowell & Moring LLP has continued to make its mark in the arena, recently guiding Ralph Lauren Corp. and a Lindsey Manufacturing Co. Executive to successful outcomes in FCPA cases." The factors considered in selecting the winners included the number of attorneys at the firm working on FCPA matters and contributions to this developing area of law, including working on landmark FCPA cases, as well as client representations and outcomes.
Phil Inglima, partner in the firm's White Collar & Regulatory Enforcement Group and resident of the Washington, D.C. office, tells Law360 why he is concerned about the shrinking pardon power of the president, and about how his mentor helped him become the lawyer he is today in Law360's "Practice Leader Q&A."


text:
0 Items
Go to Basket
You have no items in your Basket.
Sign up to get notified when this product is back in stock
Sorry but this product is currently out of stock. Please check back again in a few days.
Bottled by Gordon and Macphail, probabaly a 25 years old Speyside whisky.
Receive special offers and news about our latest arrivals.
Constantine Stores Ltd
Telephone UK: (+44) 01326 340226
Fax UK: (+44) 01326 340182
Email: firstname.lastname@example.com
Registered in England. Company No. 00444452. VAT Registration No. GB 131 6122 18.
Registered Office: Constantine Stores Ltd 30 Fore Street Constantine Falmouth Cornwall TR11 5AB.
© Copyright Drink Finder – Over 3000 Alcoholic Drinks to Buy Online – 01326 340226
Development and Design by Inspired Development Ltd.
Web Design Cornwall.


text:
Dead Space - Xbox 360
4.5 stars - Pocket-lint recommended
Absolutely stunning atmosphere, fantastically well conceived fighting, incredible looks
Not the lengthiest game ever, not as terrifying as Silent Hill
Titles created with the intention of inducing a bit of a stink in your boxers certainly aren't anything new. Every branch of this phenomena known as entertainment has been jam packed with pieces knocked up with almost the sole intention to scare you witless.
And Dead Space, initially at least, seems to be just another tacked on the end of this particularly long line. It's set in space. It involves lost contact. It sends you out on your own after the first few minutes of play. It features lots of gruesome monsters. And it's really quite dark. So far, so standard.
Your character, Isaac Clarke (presumably named after the seminal science fiction writers Isaac Asimov and Arthur C Clarke) is part of a crew approaching the hulking ship, the Planet Cracker USG Ishimura. But for Clarke this is anything but routine. He receives a cryptic message from one Nicola Brennan, an officer aboard the Ishimura as they approach the strangely silent ship. And for Clarke he needs to find out just what's going on.
Immediately things go pear shaped, and Clarke is forced far away from his team, deeper into the depths of the Ishimura. What proceeds is the kind of search and collect title we've all seen a thousand times before, complete with unusual monsters.
Bit differences start to make themselves known only a half hour in. As Clarke is anything but one au fait with weaponry, you won't find yourselves in possession of the standard kinds of guns you expect from all these action/adventure style of titles. Instead you'll wield mining instruments you pick up along the way.
The way you take out the monsters - grotesquely deformed humanoid-esque creatures presumably mutated from the Ishimura's original crew - is a little different too. Information left from crew members, from voice recordings through to crude sentences written on walls in blood, gives hints that the usual "aim for the head" style of gaming won't work for you here.
Dismemberment is the way to go, with each variation of monster having their own plus and minus points. For most, blasting off the legs is the way to go, leaving you able to slowly make sure that they're firmly dead. But be sure to make certain that they're long gone, as each will happily mutate and sneak up behind you and snatch away chunks of your tiny health bar.
Another unusual Dead Space phenomenon is the lack of traditional display on screen with regards to your ammo and health. It's all about the visual clues, from the meter built in to Clark's suit spine, through to readouts on your weapons themselves. And if you're ever a bit lost and don't want to head out to the map - the game wont pause in this situation, so you'll get no respite - you just need to click the right analogue stick and Clarke will beam a luminous line along the ground pointing you in the right direction for a few seconds.
The lack of HUD only helps maintain Dead Space's incredible sense of atmosphere. It's certainly not the scariest game out there (though it certainly does get more terrifying as you progress through the 12 chapters on offer) but it packs a real sense of being. Every second you play you'll be sat right on the edge of your seat, peering into the blackness and living the world that Clarke finds himself in.
The cracking visuals certainly don't hinder matters either. Though screenshots look beautiful enough, to see the game in motion is to allow a real treat for the eyes. Everything from the glowing lights of Clarke's suit, through to the fantastic animation of your enemies is done to the typical high EA standard. Special mention needs to go to the aural experience too, particularly when in a vacuum with its muffled effects.
It might not be anything new for the genre, but the stunning application sends it right to the top of the genre.
In almost every way this is pretty much the best a horror title has to offer, with only the slightly lower standard of scares compared to Silent Hill as a true minus point. Certainly one to buy.
Ubisoft's next Far Cry title goes primal with Stone Age setting, coming 2016
Microsoft HoloLens gets $3,000 price and Project X-Ray mixed reality game revealed
Hanging around with Nathan Drake: Pocket-lint chats to Nolan North about gaming superstardom
Forza Motorsport 6 review: The Forza is strong with this one
- Ubisoft's next Far Cry title goes primal with Stone Age setting, coming 2016
- Microsoft HoloLens gets $3,000 price and Project X-Ray mixed reality game revealed
- Hanging around with Nathan Drake: Pocket-lint chats to Nolan North about gaming superstardom
- Forza Motorsport 6 review: The Forza is strong with this one
- Can't afford the Xbox One Elite controller? Don't worry, you'll be able to remap your existing controller buttons
- Halo 5 limited edition Xbox One controllers now available: This is what they look like
- Watch first trailer for episode one of Minecraft: Story Mode, coming this month
- PS4 System Software 3.0 Kenshin coming tomorrow, what will you get?
- Project Spark for Xbox One and Windows goes completely free from 5 October
- Lego Dimensions review: Everything Is Awesome
- Best smartphones 2015: The best phones available to buy today
- Apple iPad Pro vs Microsoft Surface Pro 4
- Microsoft Lumia 950, Lumia 950 XL vs Apple iPhone 6S, iPhone 6S Plus vs Google Nexus 5X, Nexus 6P: What's the difference between the flagships?
- Castrol Nexcel gives you a 90 second engine oil change, debuts on Aston Martin Vulcan
- Dell XPS 15 adds infinity display for 2016 model, XPS 13 sees power bump
- Best Windows 10 laptops to look forward to in 2015
- HP takes on Apple Music and Spotify with HP Lounge, free unlimited music streaming
- DJI Osmo is basically a pricey selfie stick that can shoot steady vids in 4K
- 18 real-life robots that will make you think the future is now
- Light L16 Camera wants to beat DSLR with its 16 lenses and 52-megapixel shots


text:
The applicability of urinary creatinine as a method of specimen normalization in the cystic fibrosis population
ABSTRACT Urine specimens are commonly used in biomarker research. Urinary creatinine (UCr) is often used to adjust for urine analyte concentration. We aim to explore the applicability of UCr as a normalization method in a cystic fibrosis (CF) population during hospitalization.
Multiple spot urine samples were collected from CF patients hospitalized for a pulmonary exacerbation. Single spot specimens were obtained from asthmatics and healthy children for comparison. The assumptions and implications from the use of UCr as a normalization factor for urinary desmosine measurements were investigated.
UCr differed significantly across disease groups and decreased significantly over time in the CF population. Differing results were obtained when contrasting normalization by UCr with specific gravity.
UCr levels are not completely attributable to simply variations in urine concentration. Analysis of urinary biomarker measurements should be initiated with an understanding of the relative effects of the normalization process on the results.
Full-textDOI: · Available from: Theresa A Laguna, Sep 26, 2015
- SourceAvailable from: Kai Wang
[Show abstract] [Hide abstract]
- "One interesting possibility is to use the level of other biomolecules in body fluids such as creatinine levels in blood and urine to normalize miRNAs. The levels of creatinine have been used to " normalize " other biomolecules in urine, and it provides an interesting possibility as a normalization basis for miRNAs in plasma and urine [70] [71]. "
ABSTRACT: MicroRNAs (miRNAs) are a recently discovered class of small, non-coding RNAs that regulate protein levels post-transcriptionally. miRNAs play important regulatory roles in many cellular processes, including differentiation, neoplastic transformation, and cell replication and regeneration. Because of these regulatory roles, it is not surprising that aberrant miRNA expression has been implicated in several diseases. Recent studies have reported significant levels of miRNAs in serum and other body fluids, raising the possibility that circulating miRNAs could serve as useful clinical biomarkers. Here, we provide a brief overview of miRNA biogenesis and function, the identification and potential roles of circulating extracellular miRNAs, and the prospective uses of miRNAs as clinical biomarkers. Finally, we address several issues associated with the accurate measurement of miRNAs from biological samples.Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 03/2011; 717(1-2):85-90. DOI:10.1016/j.mrfmmm.2011.03.004 · 3.68 Impact Factor
Article: Iron speciation in human cancer cells by K-edge total reflection X-ray fluorescence–X-ray absorption near edge structure analysis[Show abstract] [Hide abstract]
ABSTRACT: X-ray absorption near edge structure (XANES) analysis in combination with synchrotron radiation induced total reflection X-ray fluorescence (SR-TXRF) acquisition was used to determine the oxidation state of Fe in human cancer cells and simultaneously their elemental composition by applying a simple sample preparation procedure consisting of pipetting the cell suspension onto the quartz reflectors. XANES spectra of several inorganic and organic iron compounds were recorded and compared to that of different cell lines. The XANES spectra of cells, independently from the phase of cell growth and cell type were very similar to that of ferritin, the main Fe store within the cell. The spectra obtained after CoCl2 or NiCl2 treatment, which could mimic a hypoxic state of cells, did not differ noticeably from that of the ferritin standard. After 5-fluorouracil administration, which could also induce an oxidative-stress in cells, the absorption edge position was shifted toward higher energies representing a higher oxidation state of Fe. Intense treatment with antimycin A, which inhibits electron transfer in the respiratory chain, resulted in minor changes in the spectrum, resembling rather the N-donor Fe-α,α′-dipyridyl complex at the oxidation energy of Fe(III), than ferritin. The incorporation of Co and Ni in the cells was followed by SR-TXRF measurements.Spectrochimica Acta Part B Atomic Spectroscopy 03/2011; 66(3-4-3-4):274-279. DOI:10.1016/j.sab.2011.03.011 · 3.18 Impact Factor
Article: 257 oral FEASIBILITY OF DOSE DIFFERENCE ASSESSMENTS FOR ADAPTIVE RADIOTHERAPY IN ROUTINE PRACTICE WITH TOMOTHERAPYRadiotherapy and Oncology 05/2011; 99. DOI:10.1016/S0167-8140(11)70379-6 · 4.36 Impact Factor